Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
Location: Ireland, Dublin City, Dublin
Employees: 51-200
Total raised: $51.03M
Founded date: 2017
Investors 3
| Date | Name | Website |
| 25.04.2025 | Molten Ven... | moltenvent... |
| - | Irrus Inve... | irrusinves... |
| - | Halo Busin... | hban.org |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 10.01.2025 | Series C | $32.3M | Molten Ven... |
| 01.02.2023 | - | $4.25M | Seroba Lif... |
| 23.05.2022 | Series B | $12.18M | - |
| 21.05.2019 | - | $2.3M | - |
Mentions in press and media 22
| Date | Title | Description |
| 30.07.2026 | Qureight Secures $20M for AI-Powered Clinical Trials | Qureight secured $20 million in Series B funding. Molten Ventures led the round, joined by existing investors. This capital fuels Qureight's AI-powered imaging platform. It targets lung and heart clinical trials. The technology accelerates ... |
| 29.07.2026 | Qureight Raises $20M for AI-powered Lung and Heart Clinical Trials | Qureight just raised $20 million to fix how to read a chest scan. The Cambridge company builds AI imaging tools for lung and heart clinical trials, and its Series B was led by Molten Ventures, with backers Hargreave Hale AIM VCT, XTX Ventur... |
| 06.05.2025 | Deciphex Reinforces Growth Trajectory in Global Pathology with Appointment of Industry Leader Greg Wigmore as CFO | Deciphex, a global leader in expert-led pathology services, announces the appointment of Greg Wigmore as Chief Financial Officer. Wigmore brings over 25 years of diagnostics industry experience, including senior roles at Danaher's Leica Bio... |
| 10.01.2025 | Deciphex Secures $32.3M for AI-Powered Digital Pathology | What You Should Know: – Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from AC... |
| 09.01.2025 | Deciphex: $32.3 Million (Series C) Raised For Addressing The Global Pathology Crisis | Deciphex, an AI-based digital pathology leader, announced it has closed its Series C funding at $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Sero... |
| 08.01.2025 | Deciphex's €31M Series C Funding: A Leap Towards Faster Diagnoses | In the world of healthcare, time is often the difference between life and death. The faster a diagnosis is made, the quicker treatment can begin. Enter Deciphex, a Dublin-based startup that is reshaping the landscape of digital pathology. R... |
| 07.01.2025 | Molten leads €31M Series C In Deciphex's pathology platform | Deciphex, an AI-powered digital pathology startup, has raised a €31M Series C round led by Molten Ventures. The round also featured significant participation from ACT Venture Capital, Seroba, Charles River Laboratories, IRRUS Investments, H... |
| 07.01.2025 | Deciphex Raises €31M in Series C Funding | Deciphex, a Dublin, Ireland-based AI-powered digital pathology company, raised €31M in Series C funding. The round was led by Molten Ventures with participation from ACT Venture Capital, Seroba, Charles River Laboratories (NYSE: CRL), IRRUS... |
| 07.01.2025 | Deciphex Secures $32.3M Series C to Address Global Pathology Shortage | DUBLIN–(BUSINESS WIRE)–January 7, 2025– Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant parti... |
| 03.12.2024 | Busting the myths of venture debt: when and how to use it to fuel growth (and why it's not a company killer) | Author: Antony Baker, Principal at Claret Capital Partners “Venture debt is a killer”, “venture debt should not exist”, “companies should not draw venture debt…” Recently, there have been various public, blanket, statements on venture debt,... |
Show more